Funding
In recent years, the global fintech revolution has not slowed down, especially in Europe and the UK. The advent of PSD3 (Payments Services Directive), other tenants of fintech regulation and innovation have almost guaranteed expansion in the sector, and we can trace more than $2.26 trillion of the cumulative value of fintechs across the world from Europe.
HackerPulse, a platform that gives technical leaders advanced visibility into engineering team performance, has raised $1.5 million in seed funding. The round was led by AltaIR Capital, with participation from Antler, DVC Fund and angel investors including 15 engineering leaders from Uber, Cloudflare, Deel, SpaceX, Google. The company equips engineering leaders with ML-powered tools to identify inefficiencies, streamline workflows, and optimise team structures.
Cino – the only real-time shared payment app that finally lets people pay together in a seamless, single transaction – has raised €3.5 million in Seed funding led by Balderton Capital. Connect Ventures also participated alongside leading angels, including Barney Hussey-Yeo (founder of Cleo). The funding will support Cino’s launch in the UK, where it already has a growing waitlist, and continued growth across Europe.
Trying to secure investment in your company from venture capitalists can be very daunting for leaders of SMEs or startups. It could have taken you years of hard work to realise your business goals, and now you find yourself negotiating the complex and cutthroat world of finance with experienced, shrewd professionals who might want a significant share of your operation.
Moonwatt – the energy storage startup founded by seasoned professionals with a track record at global leaders like Tesla, EDF, Siemens, Scatec, and Freyr Battery – has raised €8 million to unlock the true, 24/7 power of solar with its disruptive sodium-ion battery system. Co-led by daphni and LEA Partners, Founders Future, AFI Ventures (by Ventech) and Kima Ventures also participated alongside strategic business angels and customers. The funding will be used to accelerate the development and deployment of Moonwatt’s hardware and software technology, expand the team and drive the shift toward a cleaner, more resilient global energy ecosystem.
Heidi, the healthcare AI company whose AI scribe is transforming how clinicians work, has raised $16.6 million in its latest funding round. The Series A follow-on investment is led by Headline, with participation from Local Globe, Anthology (Menlo Ventures and Anthropic), and existing investors Blackbird, HESTA, Possible Ventures, and Archangel Ventures.
Unique, a vertical AI player creating a specialised agentic AI platform for financial firms, today announced the successful completion of its Series A funding round, raising $30 million. Unique’s total investment now stands at $53 million since its founding in 2021. This round is led by CommerzVentures and DN Capital, with continued support from existing seed investors including VI Partners and Pictet Group.
Electric Sheep, a UK-based AI tech startup, announces a major milestone as it secures Innovate UK’s prestigious £500,000 Smart Grant – an award recognising its advancements in AI-driven visual effects (VFX) technology. This funding will support the development of Spotlight V3, Electric Sheep’s next-generation rotoscoping tool, set to launch in early 2025.
Ignota Labs, the AI-driven drug turnaround company, has announced the close of a $6.9 million (£5.5 million) seed funding round, co-led by Montage Ventures and AIX Ventures with participation from Modi Ventures, Blue Wire Capital, and Gaingels. The funding will be used to expand the pipeline by acquiring additional distressed assets and for advancement into early-stage clinical trials of their first asset, a PDE9A inhibitor.
Gene therapy’s biggest obstacle isn’t science – it’s manufacturing. While the field races forward with breakthrough treatments, production remains stuck in the 1980s, relying on unpredictable cell-based methods that make therapies costly and slow to develop. Fuse Vectors has announced $5.2 million in pre-seed financing led by HCVC to revolutionise gene therapy development with its cell-free viral vector technology.









